Drugs / aH5N8c
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05874713 | Jun 2023 → Apr 2024 | influenza | Seqirus | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | aH5N8c | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05874713 ↗ |
| Modality | Vaccine | “influenza vaccine” NCT05874713 ↗ |
| Route | Intramuscular | “for intramuscular administration” NCT05874713 ↗ |